These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 8883411)

  • 1. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
    Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
    Br J Cancer; 1996 Oct; 74(8):1242-7. PubMed ID: 8883411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators.
    Levesque MA; Clark GM; Yu H; Diamandis EP
    Br J Cancer; 1995 Sep; 72(3):720-7. PubMed ID: 7545416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study.
    Rowlands MA; Tilling K; Holly JM; Metcalfe C; Gunnell D; Lane A; Davis M; Donovan J; Hamdy F; Neal DE; Martin RM
    Cancer Causes Control; 2013 Jan; 24(1):39-45. PubMed ID: 23085814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
    Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
    J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and tissue mRNA levels of IGFBP-2 and IGFBP-4 in the ovine fetus.
    Carr JM; Owens JA; Grant PA; Walton PE; Owens PC; Wallace JC
    J Endocrinol; 1995 Jun; 145(3):545-57. PubMed ID: 7543554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-3 and breast cancer survival.
    Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
    Int J Cancer; 1998 Dec; 79(6):624-8. PubMed ID: 9842972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of IGFs and IGFBPs mRNA levels and tissue concentrations in liver, kidney and skeletal muscle of pig.
    Peng M; Pelletier G; Palin MF; Véronneau S; LeBel D; Abribat T
    Growth Dev Aging; 1996; 60(3-4):171-87. PubMed ID: 9007568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.
    Lawrence JB; Conover CA; Haddad TC; Ingle JN; Reid JM; Ames MM; Suman VJ; Marks RS; Erlichman C; Hartmann LC
    Clin Cancer Res; 1997 Oct; 3(10):1713-20. PubMed ID: 9815555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
    Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
    Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer.
    Yee D; Sharma J; Hilsenbeck SG
    J Natl Cancer Inst; 1994 Dec; 86(23):1785-9. PubMed ID: 7525978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).
    Fottner C; Engelhardt D; Weber MM
    Horm Metab Res; 1999; 31(2-3):203-8. PubMed ID: 10226803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues.
    McGuire SE; Hilsenbeck SG; Figueroa JA; Jackson JG; Yee D
    Cancer Lett; 1994 Feb; 77(1):25-32. PubMed ID: 7512885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of progesterone on simultaneous, local secretion of IGFBP-3 and IGF-I [IGFBP-3/IGF-I index] by human malignant and non-malignant breast explants depends on tissue steroid receptor phenotype.
    Krzysiek J; Milewicz T; Augustowska K; Sztefko K; Ryś J; Zubel A; Pityński K; Jaszczyński P; Herman K; Basta A; Stachura J; Gregoraszczuk EŁ
    Ginekol Pol; 2003 Sep; 74(9):767-74. PubMed ID: 14674122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
    Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
    Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IGF-binding protein-6 and prostate specific antigen in breast cancer.
    Kaulsay KK; Ng EH; Ji CY; Ho GH; Aw TC; Lee KO
    Eur J Endocrinol; 1999 Feb; 140(2):164-8. PubMed ID: 10069662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
    Noll K; Wegmann BR; Havemann K; Jaques G
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.
    Rowlands MA; Holly JM; Gunnell D; Donovan J; Lane JA; Hamdy F; Neal DE; Oliver S; Smith GD; Martin RM
    Cancer Res; 2012 Jan; 72(2):503-15. PubMed ID: 22106399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.